Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced a poster ...
Thrivent Small Cap Stock Fund underperformed its benchmark due to Health Care selection and AI-related volatility. Read the ...
TI-0032 first-in-human study initiated; US/China dual IND filing on trackBEIJING & SHANGHAI--(BUSINESS ...
Market Volatility Certara (NASDAQ:CERT) reported first-quarter 2026 revenue of $106.9 million, up 1% from the prior-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results